Tag: gBRCA mutation

AstraZeneca: India's drug regulator orders withdrawal of AstraZeneca's cancer drug due to potential adverse effects | – Times of India

Health and Lifestyle

May 24, 2024 admin

[ad_1] The Drug Controller General of India (DCGI) has asked all state drug regulators to withdraw AstraZeneca‘s anti-cancer drug Olaparib tablets. This drug which is […]

Tag: gBRCA mutation

AstraZeneca: India's drug regulator orders withdrawal of AstraZeneca's cancer drug due to potential adverse effects | – Times of India

Categories

Archives

Pages